Locaserin The novel antiobesity drug, locaserin, is an agonist at serotonin 5-HT2C receptors that are antagonized by some PTDs, inducing the adverse effect of weight gain
The metabolic effects contribute to body composition changes even after the body has gotten used to the initial appetite suppression
What makes this especially intriguing is that GLP1 effects may extend to other hedonic drives, such as highcalorie eating, hinting at shared neural circuitry
Both hepatic glucose production and pro-inflammatory cytokines contribute to hepatic insulin resistance (8, 17, 18)
Coaching + DNA insight Nutrition and habit coaching between visits, so the medication's quiet window becomes a time to rebuild eating and movement patterns
These carefully selected ingredients work together to enhance fat breakdown, improve liver function, and boost energy levels, making it an excellent addition to a weight management program